Triple therapy: Interferon + Ribavirin + incivek/victrelis.
Answered 7/1/2014
5.2k views
Lots in development: Right now standard of care is pegylated interferon plus Ribavirin for all genotypes, and adding a protease inhibitor (either telaprevir or boceprevir) for genotype 1. By the end of this year, we expect both simeprevir (a once a day protease inhibitor) and sofosbuvir (nucleotide analogue) to be approved. Genotype 2 will be all-oral. Other genotypes will still do better with interferon.
Answered 1/15/2016
5.2k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question